Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022

Jennifer L Farrar; Nathaniel M Lewis; Kennedy Houck; Michelle Canning; Amy Fothergill; Amanda B Payne; Adam L Cohen; Joshua Vance; Bridget Brassil; Erin Youngkin; Bailey Glenn; Anil Mangla; Nikki Kupferman; Katharine Saunders; Cristina Meza; Dawn Nims; Susan Soliva; Brandon Blouse; Tiffany Henderson; Emily Banerjee; Brooklyn White; Rachael Birn; Anna M Stadelman; Meaghan Abrego; Meagan McLafferty; Michael G Eberhart; Michael Pietrowski; Sandra Miranda De León; Emma Creegan; Abdoulaye Diedhiou; Caleb Wiedeman; Jade Murray-Thompson; Elizabeth McCarty; Jessica Marcinkevage; Anna Kocharian; Elizabeth A Torrone; Logan C Ray; Daniel C Payne; Mpox Cases in Vaccinated Persons Team

doi:10.1016/j.ajt.2023.01.003

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022

Am J Transplant. 2023 Feb;23(2):298-303. doi: 10.1016/j.ajt.2023.01.003. Epub 2023 Jan 11.

Authors

Jennifer L Farrar¹, Nathaniel M Lewis², Kennedy Houck², Michelle Canning², Amy Fothergill³, Amanda B Payne², Adam L Cohen², Joshua Vance⁴, Bridget Brassil⁵, Erin Youngkin⁶, Bailey Glenn⁷, Anil Mangla⁸, Nikki Kupferman⁹, Katharine Saunders¹⁰, Cristina Meza¹¹, Dawn Nims¹², Susan Soliva¹³, Brandon Blouse¹⁴, Tiffany Henderson¹⁵, Emily Banerjee¹⁶, Brooklyn White¹⁷, Rachael Birn¹⁸, Anna M Stadelman¹⁹, Meaghan Abrego²⁰, Meagan McLafferty²¹, Michael G Eberhart²², Michael Pietrowski²³, Sandra Miranda De León²⁴, Emma Creegan²⁵, Abdoulaye Diedhiou²⁶, Caleb Wiedeman²⁷, Jade Murray-Thompson²⁸, Elizabeth McCarty²⁹, Jessica Marcinkevage³⁰, Anna Kocharian³¹, Elizabeth A Torrone², Logan C Ray², Daniel C Payne²; Mpox Cases in Vaccinated Persons Team

Affiliations

¹ CDC Mpox Emergency Response Team. Electronic address: ihi4@cdc.gov.
² CDC Mpox Emergency Response Team.
³ CDC Mpox Emergency Response Team; Epidemic Intelligence Service, CDC.
⁴ California Department of Public Health; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.
⁵ Chicago Department of Public Health, Chicago, Illinois.
⁶ Colorado Department of Public Health and Environment.
⁷ Connecticut Department of Public Health; Council of State and Territorial Epidemiologists, Atlanta, Georgia.
⁸ District of Columbia Department of Health.
⁹ Delaware Department of Health and Social Services.
¹⁰ Epidemic Intelligence Service, CDC; Florida Department of Health.
¹¹ Georgia Department of Public Health.
¹² Illinois Department of Public Health.
¹³ Massachusetts Department of Public Health.
¹⁴ Maryland Department of Health.
¹⁵ Michigan Department of Health and Human Services.
¹⁶ Minnesota Department of Health.
¹⁷ Missouri Department of Health and Senior Services.
¹⁸ Council of State and Territorial Epidemiologists, Atlanta, Georgia; Nebraska Department of Health and Human Services.
¹⁹ Epidemic Intelligence Service, CDC; New Mexico Department of Health.
²⁰ New York State Department of Health.
²¹ Oregon Health Authority, Public Health Division.
²² Pennsylvania Department of Health.
²³ City of Philadelphia Department of Public Health, Philadelphia, Pennsylvania.
²⁴ Puerto Rico Department of Health.
²⁵ Rhode Island Department of Health.
²⁶ South Carolina Department of Health and Environmental Control.
²⁷ Tennessee Department of Health.
²⁸ Utah Department of Health and Human Services.
²⁹ Virginia Department of Health.
³⁰ Washington State Department of Health.
³¹ Wisconsin Department of Health Services.

PMID: 36695684
DOI: 10.1016/j.ajt.2023.01.003

No abstract available

MeSH terms

Demography
Humans
Mpox (monkeypox)* / diagnosis
Mpox (monkeypox)* / prevention & control
Smallpox Vaccine* / administration & dosage
Vaccination

Substances

smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
Smallpox Vaccine